Paul M. Silber
Paul M. Silber publishes mostly in Pharmacology, Surgery and Hepatology, on topics such as Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Drug-Induced Hepatotoxicity and Protection.
- World rank
- #3,599,055 of 7,710,434 ranked researchers
- Rank in United States
- #1,001,744 of 1,627,098
- Works
- 25
- Citations
- 850
- Citations per work
- 34.0
What does Paul M. Silber research?
Paul M. Silber's work is mostly in Medicine (32%), Pharmacology, Toxicology and Pharmaceutics (22%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1145.4%
- Health Sciences832.5%
- Medicine832.5%
- Life Sciences622.1%
- 1Pharmacology22% of their works
- 2Surgery7% of their works
- 3Hepatology7% of their works
- 4Oncology7% of their works
- 5Dermatology6% of their works
- 6Pediatrics, Perinatology and Child Health4% of their works
Research topics
- Pharmacogenetics and Drug Metabolism
- Drug Transport and Resistance Mechanisms
- Drug-Induced Hepatotoxicity and Protection
- Liver physiology and pathology
- Computational Drug Discovery Methods
- Organ Transplantation Techniques and Outcomes
- Peroxisome Proliferator-Activated Receptors
- Statistical Methods in Clinical Trials
Which keywords describe Paul M. Silber's research?
The keywords of their largest research topics: Pharmacokinetics, Cytochrome P450, Pharmacogenetics, Oxidative Stress, Liver Transplantation, Nuclear Receptors, Biomarkers and Inflammation.
- Peroxisome Proliferator-Activated Receptors
- False Discovery Rate
- Virtual Screening
- Ischemia-Reperfusion Injury
- Liver Regeneration
- Hepatic Stellate Cells
- Multidrug Resistance
- Inflammation
- Nuclear Receptors
- Oxidative Stress
- Cytochrome P450
- Pharmacokinetics
- Pharmacogenetics
- Liver Transplantation
- Biomarkers
- ATP-dependent Transporters
- Drug-Induced Liver Injury
- Hepatotoxicity
- Graft Survival
- Molecular Docking
- Adaptive Designs
- PPARs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 22 words, with their numbers
- Pharmacokinetics132 topics
- Cytochrome P450101 topic
- Pharmacogenetics101 topic
- Oxidative Stress82 topics
- Liver Transplantation72 topics
- Nuclear Receptors72 topics
- Biomarkers62 topics
- Inflammation62 topics
- ATP-dependent Transporters51 topic
- Multidrug Resistance51 topic
- Drug-Induced Liver Injury41 topic
- Hepatic Stellate Cells41 topic
- Hepatotoxicity41 topic
- Liver Regeneration41 topic
- Graft Survival31 topic
- Ischemia-Reperfusion Injury31 topic
- Molecular Docking31 topic
- Virtual Screening31 topic
- Adaptive Designs21 topic
- False Discovery Rate21 topic
- PPARs21 topic
- Peroxisome Proliferator-Activated Receptors21 topic
Where does Paul M. Silber work?
Paul M. Silber's main affiliation in the publication record is Institute for In Vitro Sciences, United States.
How many publications and citations does Paul M. Silber have?
OpenAlex counts 25 works and 850 citations for Paul M. Silber, an h-index of 12, ranking #3,599,055 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Paul M. Silber. Posts are plain text and can be reported.